InControl Medical Gains Expanded FDA Clearance for New InTone®MV Device Providing Men and Women a Non-Surgical Treatment Option for Urinary and Fecal Incontinence
BROOKFIELD, Wis.--(BUSINESS WIRE)--InControl Medical, LLC, a health company focusing on solutions for incontinence, has received FDA clearance for their proprietary, patented, InTone®MV, providing both men and women who suffer with urinary or fecal incontinence a non-surgical treatment option.
The InTone®MV technology was developed by the makers of InTone®, FDA listed as a Class II Medical Device for the treatment of female urinary incontinence. InTone®MV is a smaller, comfortable medical device that treats stress, urge and mixed incontinence for men and those women who suffer with vaginal atrophy.
“While InTone® has helped countless women solve the embarrassing and uncomfortable issue of involuntary loss of urine, InTone®MV allows us to expand our product line to help both men and women suffering with urinary and fecal incontinence,” says Herschel Peddicord, founder and CEO of InControl Medical.”
Both the InTone® and InTone®MV devices combine muscle stimulation with voice-guided pelvic floor exercise, visual biofeedback, and a unique, customizable probe to create a home-based treatment for incontinence. This comprehensive approach provides users with an easy-to-use program without surgery, diapers, pads or meds.
InControl Medical, LLC is responsible for developing and marketing solutions for women’s urinary incontinence including InTone® and Apex®, and has received ISO 13485 certification from the International Organization for Standardization (ISO) and the CE mark of the European Commission (EC), signifying that it meets comprehensive quality management requirements in the design and manufacture of medical devices. All products are available online at www.incontrolmedical.com.
Contacts
For InControl Medical, LLC
Suzy Ginsburg, 713-721-4774
suzy@gcomworks.com
Help employers find you! Check out all the jobs and post your resume.